• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INTUA; IMPLANTABLE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INTUA; IMPLANTABLE DEVICE Back to Search Results
Model Number V273
Device Problems Pacing Problem (1439); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Syncope/Fainting (4411); Asystole (4442)
Event Date 10/06/2022
Event Type  Injury  
Event Description
It was reported that the physician requested for a device check as this patient with a cardiac resynchronization therapy pacemaker (crt-p) exhibited syncopal episodes.This resulted in the patient experiencing asystole.Upon further investigation, it was found that this device is in safety mode.The patient was hospitalized overnight.The next day, the patient underwent a generator replacement, and the device was explanted and replaced successfully.The device is expected to be returned.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, this device was thoroughly inspected and analyzed.Interrogation of the device confirmed it was operating in safety mode due to system resets.It was confirmed that brady therapy remained available.The system resets occurred during a telemetry session and caused the device to enter safety mode.Engineers determined that this device was demonstrating behavior consistent with a high internal cell impedance within the battery.The high internal impedance resulted in the system resets due to temporary high-power consumption related to telemetry attempts and subsequent reversion to safety mode operation.
 
Event Description
It was reported that the physician requested for a device check as this patient with a cardiac resynchronization therapy pacemaker (crt-p) exhibited syncopal episodes.This resulted in the patient experiencing asystole.Upon further investigation, it was found that this device is in safety mode.The patient was hospitalized overnight.The next day, the patient underwent a generator replacement, and the device was explanted and replaced successfully.The device is expected to be returned.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTUA
Type of Device
IMPLANTABLE DEVICE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key15591118
MDR Text Key301626571
Report Number2124215-2022-41140
Device Sequence Number1
Product Code NKE
UDI-Device Identifier00802526536670
UDI-Public00802526536670
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030005/S092
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/12/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/08/2016
Device Model NumberV273
Device Catalogue NumberV273
Device Lot Number101097
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/01/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/19/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age73 YR
Patient SexMale
-
-